Articles in this Issue
Although clinical trial ethics are straightforward on paper, ethics has always been about drawing lines precisely where the science gets most tempting.
The technical challenges of polymersomes necessitate complex custom synthesis, advanced analytical characterization, and clear pathways to scale up.
Pharmaceutical manufacturers who use automation and AI models improve processes, scale more quickly, and gain the agility to meet shifting market demands.
In commercial manufacturing, the level of effort and assessment need to be proportional to the identified risk.
In vitro anti-tubercular activity of the two novel 1,2,4-triazole derivatives demonstrated dose-dependent inhibition of Mycobacterium tuberculosis.
Bulk solids handling is common in pharmaceutical manufacturing, but it remains one of the most misunderstood and underestimated engineering challenges.
When regulations contradict the natural laws of science, they may impose a substantial hardship on manufacturers.
Current practice is to apply uniform hold times across the manufacturing process, but this causes operational constraints and insufficient microbial control.
GFF treatment led to a significant improvement in FEV1% and FEV1/FVC ratios and resulted in faster, more consistent improvements than TFF.